Vanguard Group’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Sell |
560,523
-91,484
| -14% | -$245K | ﹤0.01% | 3628 |
|
|
2025
Q1 | $919K | Buy |
652,007
+7,389
| +1% | +$10.4K | ﹤0.01% | 3738 |
|
|
2024
Q4 | $1.28M | Buy |
644,618
+105,259
| +20% | +$209K | ﹤0.01% | 3687 |
|
|
2024
Q3 | $1.7M | Buy |
539,359
+135,130
| +33% | +$426K | ﹤0.01% | 3605 |
|
|
2024
Q2 | $1.28M | Buy |
+404,229
| New | +$1.28M | ﹤0.01% | 3712 |
|